The ideal drug by Haas Jimoh Akanbi PDF free download

Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs

Topics: Pharmacokinetics, Pharmacodynamics, Life Cycle of a Drug, Slow Absorption, Faster Absorption, Bioavailability, Depot Binding, Degradation, Excretion, Drug Effectiveness, Dose-response curve, Therapeutic Index, Effective dose, Lethal dose, Effective concentration, Drug Efficacy, Drug potency, Drug-drug Interactions, Cumulative Effects, Additive Effects, Synergistic Effects, Antagonistic Effects, Agonism, Antagonism, drug-receptor interaction

Topics: vomitting, nausea, Chemoreceptor trigger zone, Antiemetic Drugs, SEROTONIN ANTAGONISTS, 5-HT3 ANTAGONISTS, D2 RECEPTOR ANTAGONISTS, Prokinetic D2-receptor antagonists, Neuroleptic D2 receptor antagonists, antipsychotic receptor antagonists, NEUROKININ1 RECEPTOR ANTAGONISTS, H1-RECEPTOR ANTAGONISTS, MUSCARINIC RECEPTOR ANTAGONISTS, GLUCOCORTICOIDS, CANNABINOIDS

Topics: Drug Sources, Drug Benefit Assessment, Congeneric Drugs, Drug Administration, Oral Dosage Forms, dermatological agents, drug distribution, Drug Action, membrance permeation, drug transporters, drug elimination, drug metabolism, enteroheptaic circulation, presystemic elimination, pharmacokinetics, druig concentration, accumulation, dose-response relationship, drug-receptor interaction, agonists-antagonists, enantioselectivity, G-protein-couples receptors, plasma concentration, adverse drug effects, drug allergy, cutaenous reactions, pregnancy, lactation, drug-independent effects, cutaneous reaction, placebo theraphy, systems pharmacology, sympathetic system, cathecholamine actions, sympathomimetics, indirect sympathomimetics, Parasympathetic Nervous System, Parasympathetic Functions, Cholinergic Synapse, Parasympathomimetics, Parasympatholytics, biogenic agents, dopamine, histamine, serotonin, amino acids, vasodilators, organic nitrates, calcium antagonists, Renin-Angiotensin-Aldosterone System, ACE Inhibitors, smooth muscle, cardiac Drugs, Cardiac Glycosides, antiarrhythmic drugs, antianemic agents, anemias, iron compounds, antithrombotic agents, thrombosis therapy, Vitamin K, Heparin, fibrinolytics, platelet aggregation, plasma volume expanders, hyperlipoproteinemias, lipid-lowering agents, diuretics, water reabsorption, vasopressin, water and electrolyte disorders, Gastrointestinal Tract, Hyperacidity, antidiarrheal agents, motor system, muscle relaxants, nociceptors, pain, analgesics, eicosanoids, antipyretic analgesics, local anesthetics, opioids, General Anesthesia and General Anesthetic Drugs.lnhalational Anesthetics, Injectable Anesthetics, Anxiolytics, benzodiazepines, depressive illness, manic state, schizophrenia, endocrine system, hypothalamic hormone, hypophyseal hormone, thyroid hormone therapy, hyperthroidism, antithyroid drugs, glucocorticoid therapy, androgen, anabolic steroid, antiandrogen, follicular growth, ovulation, antibacterial drugs, antifungal drugs, antiviral drugs, antiparasitic drugs, tropical diseases, anticancer drugs, immune modulators

Topics: Oral administration, Oral drug formulations, Enteric coating, Rectal administration, Intravenous administration, Subcutaneous administration, Intramuscular administration, INJECTION TECHNIQUES, DRUG ELUTING STENTS, DRUG TRAGETING, DRUG NANOTECHNOLOGY

Topics: Cell membrane composition, drug transport, Aqueous diffusion, Lipid diffusion, Passive non-ionic diffusion, Lipid solubility, Facilitated diffusion, endocytosis, exocytosis, fluid phase phagocytosis, Filtration, Blood perfusion, P-glycoprotein, Blood flow, Tissue storage, Blood-brain barrier, Blood-testis barrier, Sertoli cell barrier, Placental barrier, Glomerular filtration, Tubular secretion, Tubular reabsorption

Topics: THERAPEUTIC WINDOW, Volume of distribution, clinical kinetics, loading dose, multiple dosing

Topics: PLANT-DRUG DISCOVERY, Drug Discovery Process, Genomics, proteomics, Current therapy, Assay Development, Hit Validation, Lead Compound, Lead Optimisation, Preclinical Evaluation, Preclinical toxicity studies, In vivo tests, Test validity, Multiple Ascending Dose, drug Development

Topics: THYROID GLAND HORMONES, Calcitonin, Triiodothyronine, Thyroxine, THYROID STIMULATING HORMONE, THYROID HORMONES, HYPERTHYROIDISM, Thyrotoxicosis, hypopthyroidism, myxedema, ENDEMIC GOITER, Grave’s disease, MULTINODULAR GOITER, PHARMACOLOGY HYPERTHYROIDISM, THYROTOXICOSIS, ANTITHYROIDS, THIOMIDES, IODIDES, RADIOACTIVE IODIDE, BETA-BLOCKERS, PHARMACOLOGY HYPOTHYROIDISM, Hypoactivity, LEVOTHYROXINE, MULTI NODULAR GLAND, SUBACUTE THYROIDITIS

Topics: Autonomic Pharmacology, autonomic drugs, Cholinoceptor-Activating Drug, Cholinesterase-Inhibiting Drug, Cholinoceptor-Blocking Drugs, Adrenoceptor Agonists Drug, Sympathomimetic Drug, Adrenoceptor Antagonist Drug, cardiovascular-renal drug, Antihypertensive Agents, Vasodilators, Treatment of Angina Pectoris, Heart Failure, Cardiac Arrhythmias, Diuretic Agents, actionson smooth muscle, central nervous system, inflammation, gout, endocrine drugs, chemotherapeutic drugs, toxicology, Heavy Metal Intoxication, Chelators, Poisoned Patient, Beta-Lactam, Cell Wall Antibiotics, Membrane-Active Antibiotics, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, Oxazolidinones, Aminoglycosides, Spectinomycin, Sulfonamides, Trimethoprim, Quinolones, Antimycobacterial Drugs, Antifungal Agents, antiviral agents, Antimicrobial Agents, Disinfectants, Antiseptics, Sterilants, Antimicrobial Agents, Antiprotozoal Drugs, Antihelminthic Drugs, Cancer Chemotherapy, Immunopharmacology, Hypothalamic Hormones, Pituitary Hormones, Thyroid drugs

Topics: Dose-Response Relationship, Pharmacokinetics, Pharmacodynamics, drug absoprtion, drug distribution, Drug Elimination, Pharmacokinetic Principles, Nervous System, Peripheral Efferent Nervous System, Parasympathomimetic Drugs, Anticbolinergic Drugs, Sympathomimetic Drugs, Adrenergic Receptor Antagonists, diuretics, Antidiuretic Drugs, Antihypertensive Drugs, Congestive Heart Failure, Antianginal Agents, Anti.anhythmic Drugs, Sedative-Hypnotic Drugs, Antipsychotic Drugs, Neuroleptic Drugs, Antidepressant Drugs, Anticonvulsants, Parkinson Disease, Alzheimer Disease, Antiepileptic Drugs, Anesthetics, Opioid Analgesics, Antagonists, AUTOCOIDS, ERGOTS, ANTI-INFLAMMATORY AGENTS, IMMUNOSUPPRESSIVE AGENTS, Histamine, Antihistamine, Serotonin Agonists, Serotonin Antagonists, Ergot Alkaloids, Eicosanoids, Salicylates and Nonsteroidal Anti-inflammatory Drugs, NSAIDs, Immunosuppressive Drugs, Hemostatic Disorder, anaemia, Antiemetics, obesity, Infectious Disease Therapy, Antibacterial Agents, Antimycobacterial Agents, Antifungal Agents, Antiparasitic Drugs, Antiviral Drugs, Antiretroviral Drugs, Cancer Chemotherapy, Alkylating Agents, Antimetabolites, Microtubule Damaging Agents, Topoisomerase Inhibitors, Antitumor Antibiotics, Antineoplastic Agents, Corticosteroids, Hormone Therapy, TOXICOLOGY, Insecticides, Herbicides, Heavy Metal Poisoning, solvents

Topics: Glucose, Diabetes, Effects of insulin, Insulin lispro, Insulin aspart, Insulin glulisine, Short acting, Insulin, Neutral protamine Hagedorn, Insulin glargine, Insulin determir, Insulin secretagogues, K-ATP Channel modulators, sulfonylureas, K-ATP modulators, Non-solfonylureas, Repaglinide, AMPK activators, Metformin, Peroxisome proliferation activating receptor gamma, Rosiglitazone, pioglitazone, GLP-1 based agents, GLP-1 receptor agonists, GLP-1 receptors, DPP-4 inhibitors, Adrenocortical Hormones

Topics: drug action, drug absoprtion, drug distribution, drug biotransformation, microsomal enzymes, drug excretion, prolongation of drug action, drug intolerance, drug hypersensitivity, chemical transmitters, 1-Acetylcholine, muscarinic receptors, nicotinic receptors, 2-Noradrenaline, Norepinephrine, Catecholamines, sympathetic depressants

Topics: drug action, Altered GIT absorption, Chelation, drug-induce mucosal damage, Passive tubular reabsorption, PHARMACODYNAMIC INTERACTION

Topics: graded potential, resting potential, depolarizing graded potential, hyperpolarizing graded potential, Neurophysiology, epilepsy, Glutamate, CNS Function, Partial Seizures, seizure, antiepileptic drugs, Clonazapam, Lorazapam, Diazepam, Phenobarbital, Phenytoin, Carbamazapine, Zonisamide, Lamotrigine, Ethosuximide, K+ channels, Valproate, Valproic Acid, Neurotransmitter release, Levetiracetam, Pleiotropic AEDs, Status Epilepticus

Topics: DRUG DISCOVERIES, LEAD COMPOUND, PHARMACOLOGICAL PROFILE IN-VITRO, TOXICOLOGY

Topics: Drug metabolizing Enzymes, Phenytoin, Xenobiotic metabolizing Enzymes, Xenobiotics, Cytochrome P450 Enzyme system

Topics: ATHEROGENESIS, Endothelial dysfunction, Smooth muscle cell dysfunction, Architectural disruption, LIPOPROTEIN PARTICLES, Primary chylomicronemia, Primary hypertriglyceridemias, Familial hypertriglyceridemia, Familial combined hyperlipoproteinemia, familial dysbetalipoproteinemia, Primary hypercholesterolemias, Familial hypercholesterolemia, Familial ligand-defective Apolipoprotein B, Familial combined hyperlipoproteinemia, hyperlipoproteinemia, Hypercholesterolemias, Hypertriglyceridemias, REDUCTASE INHIBITORS, STATINS, FIBRATES, Fibric acid derivatives, BILE ACID-BINDING RESINS, NICOTINIC ACID, NIACIN, INTESTINAL STEROL ABSORPTION, EZETIMIBE, COMBINATION THERAPY

Topics: diuretics, alpha blockers, angiotensin, receptor blocker, calcium channel blockers, vasodilators, ganglionic blockers, beta blockers

Topics: ULCERATION, Peptic ulcers, helicobacter pylori, gastric acid secretion, antiucler drugs, anti-histamine, histamine antagonist, cimetidine, tagamet, proton pump inhibitors, omeprazole, acetyl choline antagonist, mucosal defense, prostaglandin analogs, misoprostol, sucralfate, sodium bicarbonate, antacid, mucosal protection